Literature DB >> 1581110

Cell proliferation and enzyme activities associated with the development of avian tibial dyschondroplasia: an in situ biochemical study.

C Farquharson1, C Whitehead, S Rennie, B Thorp, N Loveridge.   

Abstract

Avian tibial dyschondroplasia is a disorder of endochondral ossification which results in the accumulation of noncalcified, avascular cartilage. We have investigated the changes in cell proliferation and enzyme activities within specific cell types in the growth plate of chickens with differing severity of the disease using in situ biochemical techniques that allow the quantification of enzyme activity in unfixed undecalcified sections of tissue. Lactate dehydrogenase activity in the prehypertrophic zone and tartrate-resistant acid phosphatase activity in osteoclasts/chondroclasts were not affected by the severity of the disease. Glucose 6-phosphate dehydrogenase activity in both the proliferating and prehypertrophic zones of the growth plate was reduced in chicks with both moderate and severe lesions. Cell proliferation within the proliferating chondrocytes was slightly reduced in the severely affected birds. Alkaline phosphatase activity in the prehypertrophic chondrocytes was markedly elevated in chicks with moderate and severe lesions. These results rule out an increased rate of chondrocyte proliferation as a possible mechanism for the development of tibial dyschondroplasia. The aetiology of the disease therefore appears to be related to the control of chondrocyte differentiation, mineralization, and vascularization by local and/or systemic growth factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1581110     DOI: 10.1016/8756-3282(92)90362-z

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  The biochemical characterization of aggrecan from normal and tibial-dyschondroplastic chicken growth-plate cartilage.

Authors:  C Tselepis; A P Kwan; D Thornton; J Sheehan
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Differentiation and mineralization in chick chondrocytes maintained in a high cell density culture: a model for endochondral ossification.

Authors:  C Farquharson; C C Whitehead
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

3.  Bcl-2, tissue transglutaminase and p53 protein expression in the apoptotic cascade in ribs of premature infants.

Authors:  H Y Stevens; J Reeve; B S Noble
Journal:  J Anat       Date:  2000-02       Impact factor: 2.610

Review 4.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

5.  Molybdenum-induced changes in the epiphyseal growth plate.

Authors:  N M Parry; M Phillippo; M D Reid; B A McGaw; D J Flint; N Loveridge
Journal:  Calcif Tissue Int       Date:  1993-09       Impact factor: 4.333

6.  Porcine osteochondrosis: deficiencies in transforming growth factor-beta and insulin-like growth factor-I.

Authors:  B H Thorp; S Ekman; S B Jakowlew; C Goddard
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

7.  Alterations in glycosaminoglycan concentration and sulfation during chondrocyte maturation.

Authors:  C Farquharson; C C Whitehead; N Loveridge
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

8.  Bone structure and remodelling in stroke patients: early effects of zoledronate.

Authors:  Kenneth E S Poole; Shobna Vedi; Irene Debiram; Collette Rose; Jon Power; Nigel Loveridge; Elizabeth A Warburton; Jonathan Reeve; Juliet Compston
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

9.  Bone circulatory disturbances in the development of spontaneous bacterial chondronecrosis with osteomyelitis: a translational model for the pathogenesis of femoral head necrosis.

Authors:  Robert F Wideman; Rhonda D Prisby
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.